Categories, components, and techniques in a modular construction of basket trials for application and further research
Open Access
- 4 May 2021
- journal article
- review article
- Published by Wiley in Biometrical Journal
- Vol. 63 (6) , 1159-1184
Abstract
Basket trials have become a virulent topic in medical and statistical research during the last decade. The core idea of them is to treat patients, who express the same genetic predisposition—either personally or their disease—with the same treatment irrespective of the location of the disease. The location of the disease defines each basket and the pathway of the treatment uses the common genetic predisposition among the baskets. This opens the opportunity to share information among baskets, which can consequently increase the information of the basket‐wise response with respect to the investigated treatment. This further allows dynamic decisions regarding futility and efficacy of individual baskets during the ongoing trial. Several statistical designs have been proposed on how a basket trial can be conducted and this has left an unclear situation with many options. The different designs propose different mathematical and statistical techniques, different decision rules, and also different trial purposes. This paper presents a broad overview of existing designs, categorizes them, and elaborates their similarities and differences. A uniform and consistent notation facilitates the first contact, introduction, and understanding of the statistical methodologies and techniques used in basket trials. Finally, this paper presents a modular approach for the construction of basket trials in applied medical science and forms a base for further research of basket trial designs and their techniques.Keywords
This publication has 45 references indexed in Scilit:
- Robust exchangeability designs for early phase clinical trials with multiple strataPharmaceutical Statistics, 2015
- The Brave New World of clinical cancer research: Adaptive biomarker‐driven trials integrating clinical practice with clinical researchMolecular Oncology, 2015
- The utility of Bayesian predictive probabilities for interim monitoring of clinical trialsClinical Trials, 2014
- Personalised cancer medicineInternational Journal of Cancer, 2014
- Bayesian hierarchical modeling of patient subpopulations: Efficient designs of Phase II oncology clinical trialsClinical Trials, 2013
- Borrowing Information across Subgroups in Phase II Trials: Is It Useful?Clinical Cancer Research, 2013
- Personalised medicine: not just in our genesBMJ, 2012
- Hierarchical Bayesian approaches to phase II trials in diseases with multiple subtypesStatistics in Medicine, 2003
- Surrogate End Points in Clinical Trials: Are We Being Misled?Annals of Internal Medicine, 1996
- LII. An essay towards solving a problem in the doctrine of chances. By the late Rev. Mr. Bayes, F. R. S. communicated by Mr. Price, in a letter to John Canton, A. M. F. R. SPhilosophical Transactions of the Royal Society of London, 1763